다이애딕 인터내셔널(DYAI)는 NASDAQ에 상장된 Healthcare · Biotechnology 기업입니다. 현재가 $0.78 (+0.65%), 시가총액 $0.03B, 52주 범위 $0.68 ~ $1.30.
Dyadic International, Inc., together with its subsidiaries, a biotechnology platform company, develops, manufactures, and commercializes proteins and enzymes in the United States. The company offers Dapibus Protein Production Platform, a proprietary expression system designed to produce non-animal proteins and enzymes for non-pharmaceutical markets, including life sciences, food and nutrition, and bio-industrial sector; and C1 Protein Production Platform, a thermophilic fungal platform for large-scale production of proteins. It has a research and development agreement with VTT Technical Research Centre of Finland, Ltd; license agreement with Rubic One Health to develop various livestock vacc
다이애딕 인터내셔널의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackQuant에서 실시간으로 확인할 수 있습니다.
다이애딕 인터내셔널의 현재 주가는 $0.78 (+0.65%)입니다. BlackQuant에서 실시간 시세와 차트를 확인할 수 있습니다.
다이애딕 인터내셔널의 시가총액은 약 $0.03B입니다.
Dyadic International, Inc., together with its subsidiaries, a biotechnology platform company, develops, manufactures, and commercializes proteins and enzymes in the United States. The company offers D